80 related articles for article (PubMed ID: 3260340)
21. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
22. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels.
Sheppard HW; Lang W; Ascher MS; Vittinghoff E; Winkelstein W
AIDS; 1993 Sep; 7(9):1159-66. PubMed ID: 8105806
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A.
Dreskin SC; Goldsmith PK; Gallin JI
J Clin Invest; 1985 Jan; 75(1):26-34. PubMed ID: 3871199
[TBL] [Abstract][Full Text] [Related]
24. Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV).
Müller F; Frøland SS; Brandtzaeg P
Clin Exp Immunol; 1989 Nov; 78(2):153-8. PubMed ID: 12412741
[TBL] [Abstract][Full Text] [Related]
25. [Level of HHV-6A antibodies in symptomless HIV infection as well as in the course of AIDS].
Ongrádi J; Bánhegyi D; Maródi CL; Nagy K; Csiszár A; Horváth A
Orv Hetil; 1999 Aug; 140(34):1881-5. PubMed ID: 10502970
[TBL] [Abstract][Full Text] [Related]
26. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
27. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
[TBL] [Abstract][Full Text] [Related]
28. Serum IgG subclasses in chronic and recurrent respiratory infections.
Stanley PJ; Corbo G; Cole PJ
Clin Exp Immunol; 1984 Dec; 58(3):703-8. PubMed ID: 6509800
[TBL] [Abstract][Full Text] [Related]
29. IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.
Mayumi M; Kuritani T; Kubagawa H; Cooper MD
J Immunol; 1983 Feb; 130(2):671-7. PubMed ID: 6217248
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
31. Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets.
Andrieu JM; Eme D; Venet A; Audroin C; Tourani JM; Stern M; Israel-Biet D; Beldjord K; Driss F; Even P
Clin Exp Immunol; 1988 Jul; 73(1):1-5. PubMed ID: 3262463
[TBL] [Abstract][Full Text] [Related]
32. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM
Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660
[TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
34. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
35. The natural history of human immunodeficiency virus infection among adults in Mumbai.
Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL
Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853
[TBL] [Abstract][Full Text] [Related]
36. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
37. Failure to demonstrate anti-lymphocytic antibody in serum of patients with AIDS.
Beall GN; Lal S; Sattentau QJ; Weller IV; Beverley PC
AIDS; 1987 Sep; 1(3):167-70. PubMed ID: 3126758
[TBL] [Abstract][Full Text] [Related]
38. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection.
Jacobson DL; McCutchan JA; Spechko PL; Abramson I; Smith RS; Bartok A; Boss GR; Durand D; Bozzette SA; Spector SA
J Infect Dis; 1991 Feb; 163(2):240-6. PubMed ID: 1671053
[TBL] [Abstract][Full Text] [Related]
39. Serum IgE and human immunodeficiency virus (HIV) infection.
Wright DN; Nelson RP; Ledford DK; Fernandez-Caldas E; Trudeau WL; Lockey RF
J Allergy Clin Immunol; 1990 Feb; 85(2):445-52. PubMed ID: 2303648
[TBL] [Abstract][Full Text] [Related]
40. Deterioration in immunologic status of human immunodeficiency virus (HIV)-infected homosexual men with lymphadenopathy: prognostic implications.
Spira TJ; Kaplan JE; Holman RC; Bozeman LH; Nicholson JK; Fishbein DB
J Clin Immunol; 1989 Mar; 9(2):132-8. PubMed ID: 2523901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
